Hubei Biocause Pharmaceutical Co., Ltd. (000627.SZ)

CNY 3.83

(-1.03%)

Net Income Summary of Hubei Biocause Pharmaceutical Co., Ltd.

  • Hubei Biocause Pharmaceutical Co., Ltd.'s latest annual net income in 2023 was -651.75 Million CNY , down -227.65% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd.'s latest quarterly net income in 2024 Q3 was 31.91 Million CNY , up 111.6% from previous quarter.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported an annual net income of 510.61 Million CNY in 2022, down -41.99% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported an annual net income of 880.21 Million CNY in 2021, down -21.26% from previous year.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a quarterly net income of -89.87 Million CNY for 2024 Q1, up 61.32% from previous quarter.
  • Hubei Biocause Pharmaceutical Co., Ltd. reported a quarterly net income of -275.14 Million CNY for 2024 Q2, down -206.14% from previous quarter.

Annual Net Income Chart of Hubei Biocause Pharmaceutical Co., Ltd. (2023 - 1995)

Historical Annual Net Income of Hubei Biocause Pharmaceutical Co., Ltd. (2023 - 1995)

Year Net Income Net Income Growth
2023 -651.75 Million CNY -227.65%
2022 510.61 Million CNY -41.99%
2021 880.21 Million CNY -21.26%
2020 1.11 Billion CNY -61.7%
2019 2.91 Billion CNY 120.02%
2018 1.32 Billion CNY 0.03%
2017 1.32 Billion CNY -25.44%
2016 1.77 Billion CNY 619.35%
2015 247.26 Million CNY 194.99%
2014 83.82 Million CNY 182.98%
2013 -101.01 Million CNY -954.22%
2012 11.82 Million CNY 111.63%
2011 -101.68 Million CNY -459.02%
2010 28.32 Million CNY -49.21%
2009 55.76 Million CNY 334.11%
2008 -23.81 Million CNY -126.55%
2007 89.7 Million CNY 85.48%
2006 48.36 Million CNY 581.27%
2005 7.09 Million CNY 39.47%
2004 5.09 Million CNY 110.58%
2003 -48.1 Million CNY -1014.41%
2002 5.26 Million CNY -85.87%
2001 37.22 Million CNY 8.71%
2000 34.24 Million CNY 9.26%
1999 31.34 Million CNY 3.68%
1998 30.23 Million CNY -44.81%
1997 54.77 Million CNY 48.45%
1996 36.89 Million CNY 62.06%
1995 22.76 Million CNY 0.0%

Peer Net Income Comparison of Hubei Biocause Pharmaceutical Co., Ltd.

Name Net Income Net Income Difference
COFCO Capital Holdings Co., Ltd. 1.02 Billion CNY 163.862%